US10100079: Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof
The invention relates to the development of the cationic progesterone compounds as a novel anti-tumor agent. The invention provides a method for the preparation of novel series of progesterone derivatives. The invention also provides information related to highly selective anti-cancer activities of these compounds in wide range of cancer cell irrespective of their progesterone receptor status. Thus, the disclosed cationic progesterone compounds offer a viable option as anti-cancer therapeutics.
Patent No:
US10100079
Application No:
15/649832
Filing Date:
14-07-2017
Issue Date:
16-10-2018
Applicant:
CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad
Accessibility Controls